GenomeQuest has appointed Henk Heus to scientific lead of its personalized medicine program. The new program works with pharmaceutical companies to help them transition to molecular-based research. He will manage the program's steering committee and collaborative sessions along with GenomeQuest's scientific advisors Richard Wilson and Mark Boguski.
Heus has over 15 years of experience in genomics, including at NV Organon/Akzo Nobel. He holds a PhD in human genetics from Erasmus Medical Center.
Yuan Gao has been appointed director of genomics, epigenomics, and bioinformatics at the newly founded Lieber Institute for Brain Development in Baltimore. Gao is also a founding faculty member of the institute. Previously, Gao was an assistant professor at the Center for the Study of Biological Complexity and the department of computer science at Virginia Commonwealth University. He holds a PhD and an MS in computer science from the University of Memphis, an MS in biochemistry from the University of Tennessee, and a BS in biology from Beijing University.
Foundation Medicine has appointed Maureen Cronin as senior vice president of research and product development, a newly created position. In her role, Cronin will lead development of the company's tests, which are being designed for personalized cancer treatment.
Cronin joins Foundation Medicine from Genomic Health, where she held a variety of positions, most recently as the company's vice president of translational research. Prior to Genomic Health, Cronin was senior director of Aclara BioSciences, and also spent seven years at Affymetrix. She holds a BS and an MS from the University of California, Davis, department of animal physiology, and a PhD from UCSD's department of physiology and pharmacology and the school of medicine.